Avelumab (anti-PD-L1)

Ask supplier a question | View on supplier's website

Avelumab (anti-PD-L1) (MSB0010718C) is a fully human IgG1 monoclonal antibody that targets the protein programmed death-ligand 1 (PD-L1). Avelumab exhibits potential antibody-dependent cell-mediated cytotoxicity and is used for the treatment of several kinds of carcinoma. MW=143.8 kDa.

Supplier	Selleck Chemicals
Product #	A2015
Sku #	A2015-1mg
Pricing	1mg, $367.00

Feedback